[go: up one dir, main page]

HUE063529T2 - Szélesspektrumú vakcina madár reovírus ellen - Google Patents

Szélesspektrumú vakcina madár reovírus ellen

Info

Publication number
HUE063529T2
HUE063529T2 HUE15771652A HUE15771652A HUE063529T2 HU E063529 T2 HUE063529 T2 HU E063529T2 HU E15771652 A HUE15771652 A HU E15771652A HU E15771652 A HUE15771652 A HU E15771652A HU E063529 T2 HUE063529 T2 HU E063529T2
Authority
HU
Hungary
Prior art keywords
broad
vaccine against
avian reovirus
against avian
spectrum vaccine
Prior art date
Application number
HUE15771652A
Other languages
English (en)
Inventor
Henk Pouwels
Van De Saskia Zande
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of HUE063529T2 publication Critical patent/HUE063529T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HUE15771652A 2014-10-03 2015-10-02 Szélesspektrumú vakcina madár reovírus ellen HUE063529T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14187650 2014-10-03

Publications (1)

Publication Number Publication Date
HUE063529T2 true HUE063529T2 (hu) 2024-01-28

Family

ID=51663053

Family Applications (3)

Application Number Title Priority Date Filing Date
HUE15771652A HUE063529T2 (hu) 2014-10-03 2015-10-02 Szélesspektrumú vakcina madár reovírus ellen
HUS2400031C HUS2400031I1 (hu) 2014-10-03 2024-09-24 Szélesspektrumú vakcina madár reovírus ellen
HUS2400032C HUS2400032I1 (hu) 2014-10-03 2024-09-24 Szélesspektrumú vakcina madár reovírus ellen

Family Applications After (2)

Application Number Title Priority Date Filing Date
HUS2400031C HUS2400031I1 (hu) 2014-10-03 2024-09-24 Szélesspektrumú vakcina madár reovírus ellen
HUS2400032C HUS2400032I1 (hu) 2014-10-03 2024-09-24 Szélesspektrumú vakcina madár reovírus ellen

Country Status (10)

Country Link
US (1) US10493147B2 (hu)
EP (1) EP3200820B1 (hu)
CN (1) CN106794242B (hu)
BR (1) BR112017006620B1 (hu)
ES (1) ES2954910T3 (hu)
FR (1) FR24C1042I1 (hu)
HU (3) HUE063529T2 (hu)
PL (1) PL3200820T3 (hu)
RU (1) RU2701808C2 (hu)
WO (1) WO2016050961A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3106341A1 (en) * 2018-07-13 2020-01-16 Biomune Company New vaccines against avian reoviruses
RU2750865C1 (ru) * 2020-04-09 2021-07-05 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Поливалентная инактивированная вакцина против риемереллёза, пастереллёза и сальмонеллёза индеек, уток и гусей, способ её получения
CN113907046A (zh) * 2021-11-09 2022-01-11 福建省连江县刘氏兔业养殖场 一种含特异性转移因子的ty26种兔群的选育方法和相应兔品系的培育方法
CN117659139B (zh) * 2023-11-09 2024-11-08 中国兽医药品监察所 一种检测禽呼肠孤病毒抗体的间接elisa试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5525342A (en) 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same
EP1024189B1 (en) 1999-01-29 2005-04-06 Akzo Nobel N.V. Novel antigenic class of avian reoviruses
EP1551961A2 (en) 2002-10-09 2005-07-13 Akzo Nobel N.V. Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
CN1895667B (zh) * 2006-06-06 2010-11-03 瑞普(保定)生物药业有限公司 一种呼肠孤病毒灭活疫苗及制备方法
US8178110B2 (en) * 2006-10-25 2012-05-15 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
WO2009093251A2 (en) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Reovirus vaccine based on sigma c protein sequence
EP2471926A3 (en) 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
US9359602B2 (en) 2011-05-26 2016-06-07 Intervet Inc. Immunostimulatory oligodeoxynucleotides
MX2013013801A (es) 2011-05-26 2013-12-16 Intervet Int Bv Oligodesoxinucleotidos inmunoestimuladores.
CA3040110A1 (en) * 2015-10-13 2017-04-20 Daniel C. Carter Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications

Also Published As

Publication number Publication date
EP3200820B1 (en) 2023-07-05
FR24C1042I1 (fr) 2024-12-06
BR112017006620B1 (pt) 2023-12-26
CN106794242B (zh) 2021-11-30
EP3200820A1 (en) 2017-08-09
WO2016050961A1 (en) 2016-04-07
BR112017006620A2 (pt) 2017-12-12
RU2017114503A (ru) 2018-11-06
HUS2400032I1 (hu) 2024-10-28
PL3200820T3 (pl) 2023-09-18
US20180326043A1 (en) 2018-11-15
ES2954910T3 (es) 2023-11-27
CN106794242A (zh) 2017-05-31
HUS2400031I1 (hu) 2024-10-28
US10493147B2 (en) 2019-12-03
RU2701808C2 (ru) 2019-10-01
RU2017114503A3 (hu) 2019-04-22

Similar Documents

Publication Publication Date Title
GB201410971D0 (en) Vaccine
DK3125836T3 (da) Vejrtrækningshjæpeapparat
GB201518684D0 (en) Vaccine
PL3185899T3 (pl) Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd
GB201406608D0 (en) Virus
HUS2400031I1 (hu) Szélesspektrumú vakcina madár reovírus ellen
GB201522132D0 (en) Vaccine
GB201416727D0 (en) Use
GB201419572D0 (en) Virus
GB201416716D0 (en) Use
GB201616904D0 (en) Vaccine
EP3099789A4 (en) Avian reovirus vaccines
GB201506041D0 (en) Avian vaccine
GB201608821D0 (en) Vaccines
SI3188755T1 (sl) Cepivo
GB201417214D0 (en) Vaccine
ZA201807035B (en) Reoviridae vaccine
GB201614387D0 (en) Improved vaccines
GB201603029D0 (en) Vaccine
GB201518917D0 (en) Vaccination
GB201406628D0 (en) Vaccine
TH1501006149A (th) วัคซีนสำหรับการต้านเชื้อแคมไพโลแบคเตอร์
GB201703217D0 (en) Catch
GB201412619D0 (en) Sterilisers
DK3183264T3 (da) Pegyleringsfremgangsmåde